Safety Study of Melatonin in Stroke Patients

Not yet recruiting

Phase 4 Results N/A

Summary of Purpose

The purpose of the study is to evaluate the effect of Melatonin (in a dosage of 14mg daily) for a better clinical outcome in the period three days post stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 May 2013.

1 Jul 2013 22 May 2013 1 Apr 2014 Unavailable 1 Apr 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available